Understanding Financial Toxicity in Cancer Care
Financial toxicity—a term describing the financial burden and distress faced by patients undergoing cancer treatment—is a critical issue affecting patient outcomes. Recognizing the gravity of this problem, the Atrium Health Levine Cancer Institute pioneered the Financial Toxicity Tumor Board in 2019, aiming to address these challenges comprehensively. This innovative model provides a blueprint for how healthcare institutions can better support patients facing financial struggles.
Decoding the Financial Toxicity Tumor Board
The Financial Toxicity Tumor Board is the first institution-wide initiative focusing on financial distress associated with cancer care. Similar to a regular tumor board but with an exclusive focus on financial issues, the board brings together experts from various domains—including clinical, supportive, and administrative roles—to tackle financial toxicity head-on.
Impactful Results and Systemic Changes
The board’s implementation has shown remarkable outcomes, with over 70 cases presented where more than 90% resulted in immediate solutions for individual patients and systemic improvements. It’s not just about immediate relief; it’s about creating sustainable support systems.
Financial Relief and Comprehensive Support
Over 9,321 patients have been assisted with copay support, translating to savings exceeding $10 million. Additionally, 16,495 patients have received free medications, cumulatively valued at nearly $393 million. These efforts underscore the tangible benefits of focusing on financial toxicity within cancer care.
Innovations in Patient Assistance
The board has introduced a process for patients to seek grants and financial aid from foundations and nonprofits. Financial navigators work tirelessly to connect patients with these resources, alleviating some of the financial burdens associated with cancer treatments. Additionally, the board actively addresses health insurance denials, ensuring that patients receive the necessary coverage.
Did you know?
Cancer patients often face multifaceted challenges beyond treatment itself, including transportation and daily living expenses. The Atrium Health Levine Cancer Institute’s Financial Toxicity Tumor Board has creatively addressed these issues by obtaining various grants to aid patients in these areas, highlighting the importance of holistic patient support.
Pro tip: Lessons from the Financial Toxicity Tumor Board
The unique model emphasizes collective problem-solving in real-time, ensuring financial toxicity is addressed for each patient and preventing future crises by applying solutions learned from individual cases on a larger scale.
Future Trends in Addressing Financial Toxicity in Cancer Care
Looking ahead, the success of the Financial Toxicity Tumor Board suggests a trend toward integrating economic considerations into cancer care more broadly. As healthcare systems evolve, addressing financial toxicity could become standard practice in many institutions.
Expanding Systemic Interventions
Other cancer centers are likely to adopt similar models to help mitigate financial toxicity, recognizing the vast impact it has on treatment adherence and patient outcomes. The potential for these systemic interventions to become a new standard of care is significant.
Enhancing Access to Financial Resources
Institutions might increase collaborations with nonprofit organizations and foundations to establish robust patient assistance programs. By streamlining access to financial resources, healthcare providers can alleviate patient stress and improve treatment adherence.
FAQs
What is financial toxicity?
Financial toxicity refers to the financial burden and distress experienced by patients undergoing medical treatment, which can impact their quality of life and treatment decisions.
Why is addressing financial toxicity important?
Addressing financial toxicity is crucial as it significantly affects treatment adherence, patient well-being, and overall treatment outcomes.
How can other institutions implement similar programs?
Institutions can start by forming multidisciplinary teams to assess financial barriers and create structured interventions, including partnerships with financial services and nonprofit organizations, to support patients.
Join the Conversation
We invite you to share your thoughts and experiences with financial toxicity and cancer care. Subscribe to our newsletter for more insights or leave a comment below to engage with our community of healthcare professionals and patients alike.
Keep reading